- Active not recruitingPHASE3
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older
This study looks at the long-term safety and how well a medicine called ELX/TEZ/IVA works for people with cystic fibrosis, aged 12 months and older. It continues to check on participants who have already been taking the medicine in a previous study.
For: Cystic FibrosisAustralia · Canada · Denmark - Active not recruitingPHASE3
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
This study looks at a new treatment called ELX/TEZ/IVA for cystic fibrosis, specifically for people who don't have a common gene change (F508del). It's checking if the treatment is safe and works well over a long time.
For: Cystic FibrosisAustria · Belgium · Canada